Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,434,972 papers from all fields of science
Search
Sign In
Create Free Account
VPS11 gene
Known as:
RNF108
, VPS11, CORVET/HOPS core subunit
, PEP5
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pep5, a Fragment of Cyclin D2, Shows Antiparasitic Effects in Different Stages of the Trypanosoma cruzi Life Cycle and Blocks Parasite Infectivity
Christiane B de Araujo
,
L. P. D. de Lima
,
S. Calderano
,
Flávia Silva Damasceno
,
A. Silber
,
M. C. Elias
Antimicrobial Agents and Chemotherapy
2019
Corpus ID: 73461435
Pep5 (WELVVLGKL) is a fragment of cyclin D2 that exhibits a 2-fold increase in the S phase of the HeLa cell cycle. When…
Expand
2014
2014
A Novel Intracellular Peptide Derived from G1/S Cyclin D2 Induces Cell Death*
Christiane B de Araujo
,
L. C. Russo
,
+6 authors
E. Ferro
Journal of Biological Chemistry
2014
Corpus ID: 23612715
Background: Intracellular peptides probably regulate several biological processes. Results: pep5 derived from G1/S cyclin D2…
Expand
2014
2014
Vps11, a subunit of the tethering complexes HOPS and CORVET, is involved in regulation of glycolipid degradation and retrograde toxin transport
Audun Kvalvaag
,
S. Pust
,
K. Sandvig
Communicative & Integrative Biology
2014
Corpus ID: 18325583
We recently reported that ERM (ezrin, radixin, moesin) proteins are involved in intracellular sorting of Shiga toxin (Stx) and…
Expand
2011
2011
Activated microglia inhibit axonal regeneration by RGMa
M. Kitayama
,
M. Ueno
,
T. Itakura
,
T. Yamashita
Neurosciences research
2011
Corpus ID: 53163260
2010
2010
Phylogenetic signatures of functional conservedness in lantibiotics- an in-silico regulomics study
P. Basu
,
H. Chakraborty
,
S. Ganguli
,
Paushali Roy
,
A. Datta
2010
Corpus ID: 56029296
The name Lantibiotics was introduced in 1988 as an abbreviation for "Lanthionine-containing peptide antibiotics". In spite of…
Expand
2009
2009
Nerve growth factor/nuclear factor-κB pathway as a therapeutic target in breast cancer
A. Naderi
,
L. Hughes-Davies
Journal of Cancer Research and Clinical Oncology
2009
Corpus ID: 30133303
IntroductionNuclear factor-κB pathway (NF-κB) is activated in many breast cancers. NF-кB has interactions with other pathways…
Expand
2007
2007
Peptide‐like substances as antimicrobial barriers to Corynebacterium sp. adhesion to silicone catheters
M. Fontana
,
M. Bastos
,
A. Brandelli
Letters in Applied Microbiology
2007
Corpus ID: 32827627
Aims: To show medical application of antimicrobial peptides such as Pep5 and epidermin in inhibiting adhesion of Corynebacterium…
Expand
2006
2006
[The C-terminal fragment of thymopoietin forms F-actin bundles: electron microscopic data].
Z. A. Podlubnaia
,
E. Nowak
Biofizika
2006
Corpus ID: 44260145
It was shown by electron microscopy that PEP33 a synthetic C-terminal peptide of the thymus hormone thymopoietin, formed bundles…
Expand
Highly Cited
1994
Highly Cited
1994
Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product
M. Reis
,
M. Eschbach-Bludau
,
M. I. IGLESIAS-WIND
,
T. Kupke
,
H. Sahl
Applied and Environmental Microbiology
1994
Corpus ID: 38702858
The lantibiotic Pep5 is produced by Staphylococcus epidermidis 5. Pep5 production and producer immunity are associated with the…
Expand
1987
1987
Synthetic vaccines against Friend murine leukaemia virus-induced erythroleukaemia: in vivo and in vitro studies with synthetic oligopeptides and sequence-specific antisera.
H. Bayer
,
G. Hunsmann
Journal of General Virology
1987
Corpus ID: 39236737
Biological activities of antisera against synthetic oligopeptides were examined. The peptide antisera were directed against amino…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE